Evidence map›Paper›PMID 27817845›Full record

ArticleBiological psychiatry2017

Antidepressant Actions of Ketamine Versus Hydroxynorketamine.

Graham L Collingridge, Yeseul Lee, Zuner A Bortolotto, Heather Kang, David Lodge

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Biological psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. A Time-Sensitive Plasticity Distinguishes the Rapid and Sustained Synaptic Actions of Ketamine from Its (2The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  2. Review
  3. Article
  4. ThePhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Ketamine: Neuroprotective or Neurotoxic?Frontiers in neuroscience · 2021
    Review
  9. Review
  10. Article
  11. Dendritic Spine Elimination: Molecular Mechanisms and Implications.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. BDNF at the synapse: why location matters.Molecular psychiatry · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Graham L CollingridgeCentre for Synaptic Plasticity, University of Bristol, Bristol, United Kingdom; Department of Physiology, University of Toronto, Toronto, Ontario, Canada; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. Electronic address: g.collingridge@utoronto.ca.
Yeseul LeeCentre for Synaptic Plasticity, University of Bristol, Bristol, United Kingdom.
Zuner A BortolottoCentre for Synaptic Plasticity, University of Bristol, Bristol, United Kingdom.
Heather KangCentre for Synaptic Plasticity, University of Bristol, Bristol, United Kingdom.
David LodgeCentre for Synaptic Plasticity, University of Bristol, Bristol, United Kingdom.

Funding

Medical Research Council G0601812
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antidepressive AgentsKetamineHumansAntidepressive AgentsKetamine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.